We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-15.35%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.5M
AUM Growth
-$40.1M
Cap. Flow
+$254M
Cap. Flow %
266.32%
Top 10 Hldgs %
44.8%
Holding
389
New
183
Increased
50
Reduced
47
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.6M
2
BAX icon
Baxter International
BAX
+$3.81M
3
AKBA icon
Akebia Therapeutics
AKBA
+$2.87M
4
OTIC
Otonomy, Inc.
OTIC
+$2.46M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.81M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.82M
2
CELG
Celgene Corp
CELG
+$6.57M
3
DYAX
DYAX CORPORATION
DYAX
+$6.35M
4
CMG icon
Chipotle Mexican Grill
CMG
+$5.44M
5
VTRS icon
Viatris
VTRS
+$2.57M

Sector Composition

Rank Sector Weight
1 Healthcare 48.43%
2 Technology 4.06%
3 Consumer Discretionary 2.5%
4 Consumer Staples 1.74%
5 Materials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNK
176
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$40K 0.04%
+30,000
New +$1.92M
HSY icon
177
CALL
Hershey
HSY
$34.8B
$39K 0.04%
+37,000
New +$3.3M
EFA icon
178
CALL
iShares MSCI EAFE ETF
EFA
$76.5B
$38K 0.04%
+100,000
New +$5.51M
PTCT icon
179
CALL
PTC Therapeutics
PTCT
$6.52B
$38K 0.04%
122,900
+65,800
+115% +$1.14M
INTC icon
180
PUT
Intel
INTC
$478B
$37K 0.04%
+30,400
New +$933K
PGEN icon
181
PUT
Precigen
PGEN
$1.76B
$37K 0.04%
70,630
+25,729
+57% +$810K
TCOM icon
182
CALL
Trip.com Group
TCOM
$26.7B
$37K 0.04%
+8,500
New +$356K
CASC
183
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$37K 0.04%
+68,033
New +$524K
VISN
184
CALL
Vistance Networks Inc
VISN
$2.74B
$36K 0.04%
+17,600
New +$427K
NSC icon
185
PUT
Norfolk Southern
NSC
$76.4B
$36K 0.04%
+12,500
New +$945K
WDC icon
186
CALL
Western Digital
WDC
$164B
$36K 0.04%
+7,806
New +$279K
MNST icon
187
Monster Beverage
MNST
$95.4B
$35K 0.04%
+1,578
New +$35.1K
TIF
188
PUT
DELISTED
Tiffany & Co.
TIF
$35K 0.04%
46,300
+10,800
+30% +$725K
FOLD
189
CALL
DELISTED
Amicus Therapeutics
FOLD
$34K 0.04%
+20,400
New +$144K
LRMR icon
190
CALL
Larimar Therapeutics
LRMR
$384M
$34K 0.04%
8,483
+983
+13% +$77.6K
REGN icon
191
CALL
Regeneron Pharmaceuticals
REGN
$70.9B
$33K 0.03%
13,500
-37,200
-73% -$15.3M
LNKD
192
CALL
DELISTED
LinkedIn Corporation
LNKD
$33K 0.03%
11,400
-400
-3% -$58.8K
ATHM icon
193
CALL
Autohome
ATHM
$2.48B
$32K 0.03%
+26,100
New +$686K
ILMN icon
194
CALL
Illumina
ILMN
$28.2B
$32K 0.03%
+10,280
New +$1.57M
LLTC
195
CALL
DELISTED
Linear Technology Corp
LLTC
$32K 0.03%
+17,500
New +$740K
SBUX icon
196
PUT
Starbucks
SBUX
$120B
$30K 0.03%
+74,800
New +$4.36M
TXN icon
197
CALL
Texas Instruments
TXN
$258B
$29K 0.03%
+15,100
New +$802K
INTC icon
198
CALL
Intel
INTC
$478B
$28K 0.03%
+20,900
New +$641K
TCOM icon
199
PUT
Trip.com Group
TCOM
$26.7B
$28K 0.03%
+14,000
New +$586K
AMGN icon
200
PUT
Amgen
AMGN
$198B
$27K 0.03%
36,900
+20,700
+128% +$3.08M
6 7
8
9 10

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q1 2016 Portfolio in Review

As of Q1 2016, FT Options held 389 positions worth $95.5M, down 30% from $136M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

FT Options deployed $254M of net new capital in Q1 2016, opening 183 new positions and adding to 50 existing holdings. Its largest new stake was Baxter International: 100,000 shares worth $4.11M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $8.82M trimmed.

  • FT Options's largest Q1 2016 buy was Baxter International: 100,000 shares worth $4.11M.
  • FT Options added most to Regeneron Pharmaceuticals in Q1 2016, an estimated $10.6M increase.
  • FT Options's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $8.82M.
  • FT Options fully exited Celgene Corp in Q1 2016, selling an estimated $6.57M.
  • FT Options's ten largest holdings make up 45% of its $95.5M portfolio in Q1 2016.
  • FT Options opened 183 new positions and closed 99 in Q1 2016.
  • FT Options's portfolio value fell 30% quarter-over-quarter to $95.5M.

Based on FT Options's 13F filing for Q1 2016, filed 9 May 2016.